Wu, Sherry Jingjing https://orcid.org/0000-0001-9625-1661
Dai, Min https://orcid.org/0000-0001-7584-5014
Yang, Shang-Po https://orcid.org/0009-0009-0634-4561
McCann, Cai https://orcid.org/0000-0003-2010-9794
Qiu, Yanjie
Kumar, Vipin https://orcid.org/0000-0003-2533-9089
Marrero, Giovanni J. https://orcid.org/0000-0003-1587-3624
Tsyporin, Jeremiah
Huang, Shuhan
Shin, David
Stogsdill, Jeffrey A.
Di Bella, Daniela J. https://orcid.org/0000-0001-6141-3704
Xu, Qing https://orcid.org/0000-0001-9479-470X
Chen, Bin https://orcid.org/0000-0003-1962-3593
Farhi, Samouil L. https://orcid.org/0000-0003-1359-4568
Macosko, Evan Z. https://orcid.org/0000-0002-2794-5165
Chen, Fei https://orcid.org/0000-0003-2308-3649
Fishell, Gord https://orcid.org/0000-0002-9640-9278
Article History
Received: 20 July 2024
Accepted: 2 December 2025
First Online: 21 January 2026
Competing interests
: G.F. is a founder of Regel Therapeutics, which has no competing interests with the present article.